PBMs Ask 8th Circ. To Pause FTC's Insulin Pricing Case
By Matthew Perlman · March 4, 2025, 6:26 PM EST
Caremark Rx, Express Scripts and OptumRx have asked the Eighth Circuit to pause the Federal Trade Commission's in-house case accusing the pharmacy benefit managers of artificially inflating insulin prices as they...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login